Study finds expanded access to treatment in prisons and jails can reduce opioid overdose deaths by 31.6%

PROVIDENCE, R.I. [Brown University] — The epidemic of opioid-related overdose death persists across the United States, and people released from jails and prisons are at particular risk.

While the benefits of life-saving medications for opioid use disorder (MOUD) — such as methadone, buprenorphine and extended-release (XR) naltrexone — has been documented across hospitals and treatment centers, its uptake has been extremely limited in U.S. prisons and jail settings.

In a new study published in the International Journal of Drug Policy on July 22, researchers from the Brown University School of Public Health led by Alexandria Macmadu, a doctoral candidate in epidemiology, found that expanding access to all three MOUD in prisons and jails can reduce overdose deaths by 31.6% in certain circumstances. READ MORE